COVID-19 Induced Telogen Effluvium
NCT04834102 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2021-04-06
Summary
This study inquires about the development of Telogen effluvium following the SARS-CoV-2 infection
Conditions
- Covid19
- Telogen Effluvium
- SARS-CoV Infection
- Alopecia
Interventions
- DIAGNOSTIC_TEST
-
Blood Tests
Evaluation of blood ferritin, hemoglobine, serum iron and serum iron binding capacity
Sponsors & Collaborators
-
Istanbul Medeniyet University
lead OTHER
Principal Investigators
-
Hasan AKSOY, Dr. · Istanbul Medeniyet University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-01-27
- Primary Completion
- 2021-04-27
- Completion
- 2021-04-27
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
New Treatment of Alopecia Areata
NCT05594316 ·Status: COMPLETED ·Phase: NA
-
Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants
NCT02812342 ·Status: COMPLETED ·Phase: PHASE2
-
Adipose Derived Stem Cells Versus Platelet Rich Plasma on Follicular Unit Extraction
NCT03388840 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
NCT06012240 ·Status: RECRUITING ·Phase: PHASE3
-
Oral Herbal Combination Formulation and Hair Growth in Women
NCT05019066 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy and Safety of a Dietary Supplement on Hair Growth and Hair Health in Female With Acute Telogen Effluvium
NCT06545552 ·Status: COMPLETED ·Phase: NA
-
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
NCT03898479 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata
NCT03811912 ·Status: COMPLETED ·Phase: PHASE2
-
Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis
NCT02299297 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study to Evaluate the Safety, Effectiveness and In-Use Tolerability of Hair Growth and Scalp Health Serum in Subjects With Mild to Moderate Hair Thinning.
NCT07195487 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic
NCT05098600 ·Status: COMPLETED
-
Methodology Validation: Correlating Adherent Scalp Flaking Score (ASFS) With Phototrichogram for Scalp Dandruff Evaluation in Adult Subjects
NCT06436495 ·Status: COMPLETED ·Phase: NA
-
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata
NCT06826196 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Topical Vitamin D Analogue in Treatment of Female Pattern Hair Loss
NCT06333600 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Neosil on Chronic Effluvium
NCT03659201 ·Status: COMPLETED ·Phase: PHASE4
-
Natural History and Pathogenesis of Alopecia in Children and Adults
NCT05502796 ·Status: COMPLETED
-
Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata
NCT02684123 ·Status: COMPLETED ·Phase: NA
-
Minoxidil Response Testing in Females With Female Pattern Hair Loss
NCT02206802 ·Status: COMPLETED
-
Pharmacogenomic Study of Androgenetic Alopecia
NCT01227031 ·Status: UNKNOWN
-
Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata
NCT03941548 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Fractional CO2 Laser as a Mono- or Adjuvant Therapy for Alopecia Areata
NCT04003376 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment of Alopecic Scars by Follicular Unit Extraction Hair Transplantation
NCT06145672 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study to Evaluate a Nutraceutical Supplement for Treatment of Hair Loss and Thinning in Females
NCT03052413 ·Status: COMPLETED ·Phase: NA
-
Nutraceutical Supplement With Standardized Botanicals in Males With Thinning Hair
NCT05339958 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
NCT04784533 ·Status: COMPLETED ·Phase: PHASE2